Innovating Works

FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTI...

Activa
IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un HORIZON EUROPE HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-05-10 - 2028-03-31 | Financiado
SENOXIA: Hypoxic regulation of senescent cells secretome in lung cancer and Alzheimer s disease FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA tramitó un H2020 H2020-MSCA-IF-2020 Research over the last decade has convincingly evidenced that cellular senescence and low oxygen (O2) availability (hypoxia) are distinctive...
2021-04-22 - 2024-01-09 | Financiado
VACCELERATE: VACCELERATE European Corona Vaccine Trial Accelerator Platform FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is c...
2021-02-17 - 2024-01-27 | Financiado
REVERSE: pREVention and management tools for rEducing antibiotic Resistance in high prevalence Settings FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 H2020-SC1-BHC-2018-2020 Emerging antibiotic resistance has become an endemic problem, slowly increasing under the radar and depriving future generations of effectiv...
2021-02-02 - 2026-06-30 | Financiado
ECRAID-Base: European Clinical Research Alliance on Infectious Diseases FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 H2020-SC1-BHC-2018-2020 ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) continues the activities of PREPARE, COMBACTE and ECRAID-Plan, whi...
2021-01-29 - 2026-02-28 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 H2020-SC1-BHC-2018-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
SELNET: Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Lati... FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 H2020-SC1-BHC-2018-2020 Rare cancersRare cancers are associated with poor survival, accounting for 22% of new cancer diagnoses in Europe, and 30% of cancer deaths....
2018-12-14 - 2023-12-31 | Financiado
SocketSense: Advanced sensor based design and development of wearable prosthetic socket for amputees FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 H2020-ICT-2018-20 Limb amputations cause serious physical disabilities that compromise the quality of life of many people around the globe. There are 40 milli...
2018-12-06 - 2022-12-31 | Financiado
FAIR4Health: Improving Health Research in EU through FAIR Data FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un H2020 H2020-SwafS-2018-2020 The overall objective of FAIR4Health is to facilitate and encourage European Union Health Research community to FAIRify, share and reuse th...
2018-11-30 - 2021-11-30 | Financiado
ITRIBIS: Improving Translational Research Potential at the Institute of Biomedicine of Seville FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA tramitó un FP7 The ITRIBIS project is envisaged to improve research at the Institute of Biomedicine of Seville (IBiS) and to help this center to become a r...
Financiado
OPTOBACTERIA: Multianalyte automatic system for the detection of drug resistant bacteria FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA participó en un FP7 Infectious disease are responsible of high human health burden and cost. Time to diagnosis release and quality of the microrganism detection...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.